Structure Therapeutics has the potential to have a best-in-class GLP-1 agonist drug for treatment of patients with obesity. Learn more on GPCR stock here.

America’s obesity rate looks to be plateauing—again.

Despite the latter overcoming some of the drawbacks of the former, experts say it’s not that simple, or maybe even necessary, ...

A new meta-analysis confirms that semaglutide drugs like Ozempic are not only effective for weight loss, but can also protect ...

Rejuvenating the mind and spirit and boosting metabolic health ⦁ Navratri, a festival celebrated over nine days in many parts ...

BOCA RATON, Fla.–(BUSINESS WIRE)–$VSEE–VSee Health, Inc. (Nasdaq: VSEE), a provider of comprehensive telehealth services that customize workflow streams and ...

Han is partnering with former KGI colleague Rachita Sumbria, now an associate professor in Chapman University’s School of Pharmacy, on this research. Han and Sumbria are completing a five-year grant ...

Celebrities like Oprah Winfrey are touting it. People are microdosing it. And, in the midst of a national shortage of key ...

Obesity, especially abdominal obesity, is central to the metabolic syndrome and is strongly related to polycystic ovary syndrome (PCOS) in women. Obese women are particularly susceptible to ...

It is common knowledge that obesity, excess sugar and carbohydrate intake as well as sedentary lifestyle increase the risk of ...

Sleep apnea, a common condition that prevents your body from getting enough oxygen, can be serious and lead to other health ...

The average workplace health insurance plan costs more than $25,000 amid rising prices and expensive weight-loss drugs such ...